Piroxicam nanoparticles engineered by the CESS process have batch-to-batch consistency, producing stable and pure nanoparticles every time.
Stability testing over a 3-year period has demonstrated that our engineered nanoparticles are stable. Chemical and XRD analysis both show no indication of molecule degradation.
The dissolution rates of piroxicam nanoparticles are significantly greater than those of micronized piroxicam, as tested through instrumentation developed and patented by Nanoform. Animal tests have confirmed the results of these in vitro studies.